Downloadable Slidesets

Share

Program Content

Activities

  • PARPi Monotherapy in PCa
    Single-Agent PARP Inhibitors in Prostate Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 24, 2024

  • Rationale for PARP Combos in PCa
    Leveraging Interdependencies of Targeted Pathways: Rationale for PARPi Combinations
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 24, 2024

  • PARPi Combinations in PCa
    PARP Inhibitor/AR Pathway Inhibitor Combination Approaches in Prostate Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 24, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Merck & Co., Inc., Rahway, NJ, USA.

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Merck & Co., Inc., Rahway, NJ, USA